Family summary
Current shortage references are available across related Dobutamine in Dextrose presentations from one manufacturer.
- 3 current shortage context pages.
- 0 historical shortage context pages.
- 1 manufacturer represented.
Dobutamine in Dextrose - Drug Shortage Information
Public shortage context is available across 3 visible NDC detail pages for this generic drug family.
This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.
NDC detail pages in this shortage family
Use the NDC detail page when your team needs package-level product details, public shortage references, and a supporting route into quote review workflows. These links open directly to the Drug Shortage Information section for each product page.
| Drug Name | NDC 11 | Manufacturer | Shortage Context |
|---|---|---|---|
| Dobutamine in Dextrose 100 mg / 100mL Injection 250 mL NDC 00409-2346-32 | 12 Pouch | Hospira, Inc. | 00409-2346-32 | Hospira, Inc. | Current shortage context |
| Dobutamine in Dextrose 200 mg / 100mL Injection 250 mL NDC 00409-2347-32 | 12 Pouch | Hospira, Inc. | 00409-2347-32 | Hospira, Inc. | Current shortage context |
| Dobutamine in Dextrose 400 mg / 100mL Injection 250 mL NDC 00409-3724-32 | 12 Pouch | Hospira, Inc. | 00409-3724-32 | Hospira, Inc. | Current shortage context |
Common brands and presentations in this family
These package-level links are useful for brand-name, size, and NDC-specific searches related to this shortage family.
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.